Experts say U.S. doctors overtesting, overtreating
Lindsey Tanner | 3/17/2010, 4:56 a.m.
CHICAGO — Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggest that too many Americans — maybe even President Barack Obama — are being overtreated.
Is it doctors practicing defensive medicine? Or are patients so accustomed to a culture of medical technology that they insist on extensive tests and treatments?
A combination of both is at work, but now new evidence and guidelines are recommending a step back and more thorough doctor-patient conversations about risks and benefits.
As a medical journal editorial said this week about Obama’s recent checkup, Americans including the commander in chief need to realize that “more care is not necessarily better care.”
Obama’s exam included prostate cancer screening and a virtual colonoscopy. The Postate Specific Antigen (PSA) test for prostate cancer is not routinely recommended for any age and colon screening is not routinely recommended for patients younger than 50. Obama is 48.
Earlier colon cancer screening is sometimes recommended for high-risk groups — which a White House spokesman noted includes blacks. Doctors disagree on whether a virtual colonoscopy is the best method. But it’s less invasive than traditional colonoscopies and doesn’t require sedation — or the possible temporary transfer of presidential power, the White House said.
The colon exam exposed him to radiation “while likely providing no benefit to his care,” Dr. Rita Redberg, editor of Archives of Internal Medicine, wrote in an online editorial. Obama’s experience “is multiplied many times over” at a huge financial cost to society, and to patients exposed to potential harms but no benefits.
“People have come to equate tests with good care and prevention,” Redberg, a cardiologist with the University of California at San Francisco, said in an interview last Thursday. “Prevention is all the things your mother told you — eat right, exercise, get enough sleep, don’t smoke — and we’ve made it into getting a new test.”
This week alone, a New England Journal of Medicine study suggested that too many patients are getting angiograms — invasive imaging tests for heart disease — who don’t really need them; and specialists convened by the National Institutes of Health said doctors are too often demanding repeat cesarean deliveries for pregnant women after a first C-section.
Last week, the American Cancer Society cast more doubt on routine PSA tests for prostate cancer. And, a few months ago, other groups recommended against routine mammograms for women in their 40s, and for fewer Pap tests for cervical cancer.
Experts dispute how much routine cancer screening saves lives. It also sometimes detects cancers that are too slow-growing to cause harm, or has false-positive results leading to invasive but needless procedures — and some risks. Treatment for prostate cancer that may be too slow-growing to be life-threatening can mean incontinence and impotence. Angiograms carry a slight risk for stroke or heart attack.
Not all doctors and advocacy groups agree with the criticism of screening. Many argue that it can improve survival chances and that saving even a few lives is worth the cost of routinely testing tens of thousands of people.